{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:09:06Z","timestamp":1790078946427,"version":"4.0.1"},"reference-count":21,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Introduction and Objectives: Patients with atrial fibrillation (AF) and prior ischemic stroke or transient ischemic attack (TIA) are at high risk of recurrent thromboembolic events. Although direct oral anticoagulants (DOACs) have progressively replaced vitamin K antagonists (VKAs), it remains uncertain whether prior stroke\/TIA influences anticoagulant prescribing or modifies temporal prescribing trends. Methods: This retrospective analysis included 3572 hospitalizations from the CRAFT registry between 2017 and April 2026. Hospitalization was the unit of analysis, and prior ischemic stroke\/TIA status was determined at each admission. Anticoagulant prescribing was evaluated hierarchically as OAC versus no OAC, DOAC versus VKA, DOAC molecule selection, and, in exploratory analyses, within-molecule dose selection. Multivariable logistic and multinomial models included calendar year, age, sex, hypertension, diabetes mellitus, heart failure, AF type, and estimated glomerular filtration rate, with patient-level cluster-robust standard errors. Temporal trends and their interaction with prior stroke\/TIA were assessed. Sensitivity analyses included categorical modeling of calendar year, exclusion of January\u2013April 2026, and complete-case adjustment for atherosclerotic vascular disease. Benjamini\u2013Hochberg FDR correction was applied to exploratory drug-specific comparisons. Results: Among 3572 hospitalizations, 437 (12.2%) involved patients with prior ischemic stroke\/TIA. Prior stroke\/TIA was not independently associated with OAC versus no OAC (OR 1.10, 95% CI 0.74\u20131.64; p = 0.643) or DOAC versus VKA selection (OR 0.68, 95% CI 0.45\u20131.01; p = 0.055). However, it was associated with overall DOAC molecule selection (global p = 0.0013), driven by a greater likelihood of dabigatran versus apixaban prescribing (RRR 1.87, 95% CI 1.29\u20132.72; q = 0.0052). In exploratory dose-specific analyses, prior stroke\/TIA was associated with a lower likelihood of rivaroxaban 20 versus 15 mg prescribing (OR 0.54, 95% CI 0.33\u20130.90; q = 0.047). OAC prescribing increased over time (OR per year 1.16, 95% CI 1.09\u20131.23), as did DOAC versus VKA prescribing (OR per year 1.30, 95% CI 1.23\u20131.38; both p &lt; 0.001), accompanied by a shift in DOAC molecule selection toward apixaban. Prior stroke\/TIA did not significantly modify temporal prescribing trends, and sensitivity analyses supported the principal findings. Conclusions: Anticoagulant prescribing changed substantially between 2017 and April 2026, with increasing OAC and DOAC use and marked changes in DOAC molecule selection. Prior ischemic stroke\/TIA was not independently associated with OAC use or DOAC versus VKA selection and did not significantly modify temporal prescribing trends, although differences were observed in DOAC molecule selection and exploratory dose-specific prescribing. Dose-specific findings describe prescribing patterns and should not be interpreted as assessments of dose appropriateness, efficacy, or safety.<\/jats:p>","DOI":"10.3390\/jcm15187242","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:09:35Z","timestamp":1790075375000},"page":"7242","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal Trends in Anticoagulant Prescribing in Patients with Atrial Fibrillation According to Prior Ischemic Stroke or Transient Ischemic Attack: Insights from the CRAFT Registry"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-0202","authenticated-orcid":false,"given":"Janusz","family":"Bednarski","sequence":"first","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1082-3831","authenticated-orcid":false,"given":"Micha\u0142","family":"Wojew\u00f3dzki","sequence":"additional","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Monika","family":"Szewczak","sequence":"additional","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Marta","family":"Grzesiak","sequence":"additional","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Maciej","family":"Karczewski","sequence":"additional","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Karolina","family":"W\u0142asiuk","sequence":"additional","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Emilia","family":"Kusy","sequence":"additional","affiliation":[{"name":"Clinic of Cardiology, Lazarski University, 02-662 Warsaw, Poland"},{"name":"Department of Cardiology, St. John Paul II Western Hospital, 05-825 Grodzisk Mazowiecki, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: Epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/STROKEAHA.120.029606","article-title":"Burden of stroke in Europe: Thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years","volume":"51","author":"Wafa","year":"2020","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/STROKEAHA.122.042022","article-title":"Burden of stroke in Europe: An analysis of the Global Burden of Disease Study findings from 2010 to 2019","volume":"55","author":"Prendes","year":"2024","journal-title":"Stroke"},{"key":"ref_4","unstructured":"Narodowy Fundusz Zdrowia (2026, September 09). NFZ o Zdrowiu. Udar Niedokrwienny M\u00f3zgu. Updated 19 September 2025, Available online: https:\/\/dane.gov.pl\/pl\/dataset\/3448,nfz-o-zdrowiu-udar-niedokrwienny-mozgu."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11936-014-0358-6","article-title":"Controversies in cardioembolic stroke","volume":"17","author":"Wessler","year":"2015","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.4103\/0972-2327.41719","article-title":"Cardioembolic stroke: An update on etiology, diagnosis and management","volume":"11","author":"Leary","year":"2008","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106871","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106871","article-title":"Comparison of primary and secondary stroke prevention in patients with nonvalvular atrial fibrillation: Results from the RAFFINE registry","volume":"31","author":"Yamashiro","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_10","first-page":"100003","article-title":"Suboptimal oral anticoagulation in patients with nonvalvular atrial fibrillation and history of cerebrovascular disease in Mexico: Results from the CARMEN-AF Registry","volume":"77","year":"2025","journal-title":"Rev. Investig. Clin."},{"key":"ref_11","first-page":"e658","article-title":"Prediction of ischemic stroke by the CHA2DS2-VA score in an Asian population: A report from the prospective nationwide COOL-AF registry","volume":"22","author":"Krittayaphong","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ebiom.2017.03.022","article-title":"Clinical features and prognosis in patients with atrial fibrillation and prior stroke: Comparing the Fushimi and Darlington AF registries","volume":"18","author":"Ogawa","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"De Caterina, R., Kelly, P., Monteiro, P., Deharo, J.C., de Asmundis, C., L\u00f3pez-de-S\u00e1, E., Weiss, T.W., Waltenberger, J., Steffel, J., and de Groot, J.R. (2019). Characteristics of patients initiated on edoxaban in Europe: Baseline data from Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Europe (ETNA-AF-Europe). BMC Cardiovasc. Disord., 19.","DOI":"10.1186\/s12872-019-1144-x"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e038448","DOI":"10.1161\/JAHA.124.038448","article-title":"Number of previous strokes and the association with clinical outcomes of patients with atrial fibrillation: Longitudinal data from the GLORIA-AF Registry","volume":"14","author":"Lam","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6707985","DOI":"10.1155\/2022\/6707985","article-title":"Time trends and treatment pathways in prescribing individual oral anticoagulants in patients with nonvalvular atrial fibrillation: An observational study of more than three million patients from Europe and the United States","volume":"2022","author":"Vora","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102544","DOI":"10.1016\/j.rpth.2024.102544","article-title":"Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation","volume":"8","author":"Bavalia","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ehjqcco\/qcaf002","article-title":"Temporal trends of prescription rates, oral anticoagulants dose, clinical outcomes, and factors associated with non-anticoagulation in patients with incident atrial fibrillation","volume":"11","author":"Liao","year":"2025","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gorczyca-G\u0142owacka, I., Bielecka, B., Wa\u0142ek, P., Chrapek, M., Ciba-Stemplewska, A., Jelonek, O., Kot, A., Czy\u017cyk, A., Pi\u00f3ro, M., and Major, A. (2022). Temporal trends in oral anticoagulant prescription in atrial fibrillation patients between 2004 and 2019. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095584"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e100960","DOI":"10.1136\/bmjopen-2025-100960","article-title":"Increased direct oral anticoagulant use and event rates in non-valvular atrial fibrillation: A nationwide retrospective registry study in Sweden","volume":"15","author":"Kadhim","year":"2025","journal-title":"BMJ Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.23736\/S2724-5683.24.06546-3","article-title":"Italian Registry in the Setting of Atrial Fibrillation Ablation with Rivaroxaban\u2014IRIS","volume":"72","author":"Lavalle","year":"2024","journal-title":"Minerva Cardiol. Angiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(24)00037-1","article-title":"Secondary stroke prevention in people with atrial fibrillation: Treatments and trials","volume":"23","author":"Seiffge","year":"2024","journal-title":"Lancet Neurol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7242\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:25:14Z","timestamp":1790076314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":21,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187242"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187242","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}